Sexually Transmitted Infections and Pelvic Inflammatory Disease in Women

Medical Clinics of North America

Volumn 92, Issue 5, 2008, Pages 1083-1113

  Trigg, Bruce G ^a,b   Kerndt, Peter R ^c,d   Aynalem, Getahun ^c  

^a NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c Sexually Transmitted Disease Program   (United States)

^d Los Angeles County University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTIVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; ERYTHROMYCIN ETHYLSUCCINATE; FAMCICLOVIR; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; SPECTINOMYCIN; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG; VALACICLOVIR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; CONDOM; CONDYLOMA ACUMINATUM; COUNSELING; CRYOTHERAPY; DIARRHEA; FOLLOW UP; GONORRHEA; HEADACHE; HERPES SIMPLEX; HUMAN; INFECTION RATE; LOADING DRUG DOSE; MEDICAL CARE; MEDICAL PRACTICE; MORBIDITY; MORTALITY; NAUSEA; NEISSERIA GONORRHOEAE; OUTPATIENT CARE; PELVIC INFLAMMATORY DISEASE; PHYSICIAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SCREENING TEST; SEROLOGY; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNSPECIFIED SIDE EFFECT; URETHRA DISEASE; UTERINE CERVICITIS; VIRUS CULTURE; VIRUS INFECTION; VOMITING; WART VIRUS;

FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASES;

EID: 49749099680     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.04.011     Document Type: Review

References (75)

1. Hillis S.D., Joesoef R., Marchbanks P.A., et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 168 (1993) 1503-1509
2. Hook III E.W., and Handsfield H.H. Gonococcal infections in the adult. In: Holmes K.K., Mardh P.A., and Sparling P.F. (Eds). Sexually transmitted diseases. 2nd edition (1990), McGraw-Hill, Inc., New York 149-165
3. Stamm W.E., and Holmes K.K. Chlamydia trachomatis infections in the adult. In: Holmes K.K., Mardh P.A., and Sparling P.F. (Eds). Sexually transmitted diseases. 2nd edition (1990), McGraw-Hill, Inc., New York 181-193
4. Zimmerman H.L., Potterat J.J., Dukes R.L., et al. Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health 80 (1990) 1338-1342
5. Centers for Disease Control and Prevention (CDC). 2006. Sexually transmitted diseases treatment guidelines. MMWR 55 RR-11 (2006) 1-95
6. US Department of Health and Human Services Agency for Healthcare Research and Quality. The guide to clinical preventive services: recommendations of the U.S. Preventive Services Task Force. AHRQ Publication No. 06-0588. June 2006.
7. Available at:. http://cdc.gov/std/treatment Accessed June 11, 2008
8. Available at:. http://ahrq.gov/clinic/uspstf/us/stopics.htm Accessed June 11, 2008
9. Hollblad-Fadiman K., and Goldman S.M. American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis. Am J Prev Med 24 (2003) 287-292
10. American Academy of Family Physicians. Recommendations for periodic health examinations. Available at: (2003). http://www.aafp.org/PreBuilt/PHErev54.pdf Accessed October 25, 2003
11. National Committee for Quality Assurance. The state of health care quality 2005. Industry trends and analysis (2005), National Committee for Quality Assurance, Washington, DC. http://www.ncqa.org/Doc/SOHCQ_2005.pdf Accessed June 11, 2008
12. Hessol N.A., Priddy F.H., Bolan G., et al. Management of pelvic inflammatory disease by primary care physicians: a comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis 23 (1996) 157-163
13. Institute of Medicine Committee on Prevention and Control of Sexually Transmitted Diseases. The hidden epidemic: confronting sexually transmitted diseases (1996), National Academy Press, Washington, DC
14. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of STDs among American youth, 2000 [abstract P075]. National STD Prevention Conference. Philadelphia, March 8-11, 2004.
15. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2006 (2007), U.S. Department of Health and Human Services, Atlanta (GA)
16. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type-2 in the United States, 1976 to 1994. N Engl J Med 337 16 (1997) 1105-1111
17. Leone P., Fleming D.T., Gilsenan A.W., et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 31 5 (2004) 311-316
18. Weinstock H., Berman S., and Cates Jr. W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 36 1 (2004) 6-10
19. Myers E.R., McCrory D.C., Nanda K., et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 151 (2000) 1158-1171
20. Fleming D.T., and Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 1 (1999) 3-17
21. Available at:. http://guttmacher.org/statecenter/spibs/spib_MASS.pdf Accessed June 11, 2008
22. Available at:. http://depts.washington.edu/nnptc/ Accessed June 11, 2008
23. Winer R.L., Hughes J.P., Feng Q., et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354 (2006) 2645-2654
24. Ness R.B., Randal H., Richter H.E., et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health 94 (2004) 1327-1329
25. Paavonen J., and Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 5 (1999) 433-447
26. Handsfield H.H., and Sparling P.F. Neisseria gonorrhoeae. In: Mandell G.L., Douglas R.G., and Bennett J.E. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th edition (1995), Churchill Livingstone, New York 1909-1926
27. Simms I., and Stephenson J.M. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?. Sex Transm Infect 76 (2000) 80-87
28. Westrom L., Joesoef R., Reynolds G., et al. Pelvic inflammatory diseases and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19 (1992) 185-192
29. Peterman T.A., Tian L.H., Metcalf C.A., et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 145 (2006) 564-572
30. Schillinger J.A., Kissinger P., Calvet H., et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 30 (2003) 49-56
31. Golden M.R., Whittington W.L.H., Handsfield H.H., et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 352 (2005) 676-685
32. Kissinger P., et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 41 (2005) 623-629
33. Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases (2006), US Department of Health and Human Services, Atlanta (GA). http://www.cdc.gov/std/treatment/EPTFinalReport2006.pdf Accessed June 11, 2008
34. Available at:. http://cdc.gov/std/ept/legal/default.htm Accessed June 11, 2008
35. Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections. MMWR 51 RR-15 (2002) 1-38
36. Marrazzo J.M., Handsfield H.H., and Whittington W.L. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 100 3 (2002) 579-584
37. Robinson A.J., and Ridgway G.L. Modern diagnosis and management of genital Chlamydia trachomatis infection. Br J Hosp Med 55 (1996) 388-393
38. Lau C.-Y., and Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 29 (2002) 497-502
39. McClelland R.S., Wang C.C., Mandaliya K., et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 15 (2001) 105-110
40. Gaydos C.A., Crotchfelt K.A., Howell M.R., et al. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 177 (1998) 417-424
41. Ghanem M., Radclif K., and Allan P. The role of urethral sample in the diagnosis of gonorrhea in women. Int J STD AIDS 15 (2004) 45-47
42. Barlow D., and Phillips I. Gonorrhea in women. Lancet 1 (1978) 761-764
43. Goodhart M.E., Ogden J., Zaidi A.A., et al. Factors affecting the performance of smear and culture tests for the detection of Neisseria gonorrhoeae. Sex Transm Dis 9 2 (1982) 63-69
44. Jephcott A.E. Microbiological diagnosis of gonorrhea. Genitourin Med 73 (1997) 245-252
45. Koumans E.H., Johnson R.E., Knopp J.S., et al. Laboratory testing for Neisseria gonorrhea by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 27 (1998) 1171-1180
46. CDC. Sexually transmitted disease surveillance 2004 supplement: gonococcal isolate surveillance project (GISP) Annual Report-2004 (2005), U.S. Department of Health and Human Services, Atlanta (GA)
47. Centers for Disease Control and Prevention. Update to CDC's 2006 sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 56 (2007) 332-336
48. Carne C.A. Epidemiological treatment and tests of cure in gonococcal infection: evidence for value. Genitourin Med 73 1 (1997) 12-15
49. Oxman M.N. Genital herpes. In: Gorbach S.L., Bartlett J.G., and Blacklow N.R. (Eds). Infectious diseases. 2nd edition (1998), Saunders, Philadelphia 986-1007
50. Lautenschlager S., and Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 202 (2001) 211-219
51. Corey L., Adams H.G., Brown Z.A., et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98 (1983) 958-972
52. Scoular A. Using the evidence base on genital herpes: optimizing the use of diagnostic tests and information provision. Sex Transm Infect 78 (2002) 160-165
53. Ashley R.L. Genital herpes. Type-specific antibodies for diagnosis and management. Dermatol Clin 16 (1998) 789-793
54. Koutsky L.A., Stevens C.E., Holmes K.K., et al. Under diagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326 (1992) 1533-1539
55. Whitley R.J., Kimberlin D.W., and Roizman B. Herpes simplex virus. Clin Infect Dis 26 (1998) 541-555
56. Ashley R.L., and Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 12 (1999) 1-8
57. Brown T.J., McCrary M., and Tyring S.K. Antiviral agents: non-antiretroviral [correction of nonantiviral] drugs. [published correction appears in J Am Acad Dermatol 2002;47:972]. J Am Acad Dermatol 47 (2002) 581-599
58. Whitley R.J., and Gnann Jr. J.W. Acyclovir: a decade later. [published corrections appear in N Engl J Med 1993; 328:671 and 1997; 337:1703]. N Engl J Med 327 (1992) 782-789
59. Langenberg A.G., Burke R.L., Adair S.F., et al. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann Intern Med 122 12 (1995) 889-898 [Erratum: Ann Intern Med 1995;123(5):395]
60. Hook III E.W. Acquired syphilis in adults. N Engl J Med 326 16 (1992) 1060-1069
61. Adimora A.A. Syphilis and other treponematoses. In: Kassirer J.P., and Greene H.L. (Eds). Current therapy in adult medicine. 4th edition (1997), Mosby, St Louis (MO) 289-292
62. Centers for Disease Control and Prevention (CDC). Guidelines for prevention and control of congenital syphilis. MMWR 37 S-1 (1988) 1-13
63. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 104 (1986) 368-376
64. Golden M.R., Marra C.M., and Holmes K.K. Update on syphilis: resurgence of an old problem. JAMA 290 (2003) 1510-1514
65. Romanowski B., Sutherland R., Fick G.H., et al. Serologic response to treatment of infectious syphilis. Ann Intern Med 114 (1991) 1005-1009
66. Sorvillo F., Smith L., Kerndt P., et al. Trichomonas vaginalis, HIV and African-Americans. Emerg Infect Dis 7 (2001) 927-932
67. Laga M., Manoka A., Kivuvu M., et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7 (1993) 95-102
68. Cotch M.F., Pastorek II J.G., Nugent R.P., et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24 (1997) 353-360
69. Wiese W., Patel S.R., Patel S.C., et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 108 (2000) 301-308
70. Waters W.E. Prevalence of symptoms of urinary tract infection in women. Br J Prev Soc Med 23 (1969) 263-266
71. Hamilton-Miller J.M. The urethral syndrome and its management. J Antimicrob Chemother 33 Suppl A (1994) 63-73
72. James D., and Magowan Brian A. Clinical obstetrics and gynecology (2004), Elsevier Health Sciences, United Kingdom . p. 119
73. Ness R.B., Hillier S.L., Kip K.E., et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 104 (2004) 761-769
74. Bevan C.D., Ridgway G.L., and Rothermel C.D. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res 31 (2003) 45-54
75. Scholes D., Stergachis A., Heidrich F.D., et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 334 (1996) 1362-1366